The initial US approval of AIRSUPRA was based on results from the Phase III MANDALA trial and Phase III DENALI trial (lung function trial in patients with mild to moderate asthma), and now includes ...

UPMC Children’s Community Pediatrics is seeing a noticeable uptick in cases of hand, foot and mouth, COVID and viral upper ...

New guidelines that seek to change how asthma is treated in Australia have been unveiled by Health Minister Mark Butler and ...

The global smart inhalers market size was US$ 147.7 million in 2021. The global smart inhalers market size is forecast to reach US$ 1,116.5 million by 2030, growing at a compound annual growth rate ...

Researchers assessed whether having a severe asthma exacerbation affected patients’ ICS therapy adherence in a way that improved future exacerbation outcomes.

Hospitals and clinics in Singapore emit 4.1 million tonnes of planet-warming greenhouse gases each year, which is nearly 7 ...

Philadelphia has once again been named one of the “asthma capitals” of the U.S. – ranking No. 4 in a report releas. 9, 2025.

AstraZeneca said on Wednesday its asthma drug Fasenra failed to control the rate of flare-ups in patients with chronic ...

Here are four new drug shortages and discontinuations, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists.

This week is Asthma Peak Week. As summer fades into fall, medical experts are sounding the alarm for those with asthma to ...

State data shows Detroit children have higher asthma hospitalization and death rates than other Michigan children. Learn ...